MAIN MENU
QUICK LINKS
CONNECT WITH US

Button

Clinical Trial Details

Title
Uptravi® (SelexiPag): tHe usErs dRug rEgistry (SPHERE) Registry Uptravi® (Selexipag) Users Registry PROTOCOL: AC-065A402
Study Description

The purpose of this Study is to better understand the demographic and clinical characteristics of PAH patients treated with Uptravi, to learn about the dosing and titration patterns of Uptravi (including any transition from other PAH specific therapies to Uptravi and from Uptravi to other prostanoids), and to describe the clinical course of patients treated with Uptravi.

Investigators

Principal Investigator
Vandana K. Seeram, M.B.B.S. (M.D.)
Medicine